TFIIIC63 inhibitors belong to a specific chemical class designed to target and modulate the activity of the transcription factor TFIIIC63, which plays a pivotal role in regulating gene expression. TFIIIC63 is a critical component of the RNA polymerase III transcription complex, responsible for the transcription of genes encoding essential cellular components such as transfer RNAs (tRNAs) and 5S ribosomal RNA. This transcription complex ensures the accurate and timely synthesis of these fundamental molecules, which are indispensable for protein synthesis and overall cellular function. TFIIIC63 inhibitors are designed to interfere with the binding or function of TFIIIC63, thereby exerting precise control over the transcription of RNA polymerase III-dependent genes.
The development and study of TFIIIC63 inhibitors are of great significance in the field of molecular biology and gene regulation research. These inhibitors can provide valuable insights into the intricate mechanisms underlying gene expression, allowing researchers to unravel the complexities of RNA polymerase III-dependent transcription. By selectively targeting TFIIIC63, scientists can manipulate the expression levels of specific genes, shedding light on their roles in cellular processess. Additionally, TFIIIC63 inhibitors may find applications in gene expression modulation for biotechnological purposes, such as enhancing the production of specific RNA molecules or controlling the expression of genes in various experimental settings. Overall, TFIIIC63 inhibitors hold promise as powerful tools for advancing our understanding of gene regulation and may have a wide range of applications in both basic research and biotechnology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Known to inhibit RNA polymerase II and thus could affect transcription factors downstream. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
Inhibits RNA polymerase II CTD kinase, which could impact transcription initiation. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Known to inhibit transcription initiation by the RNA polymerase II machinery. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Inhibits CDK9, affecting the transcription elongation process. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
BET bromodomain inhibitor; affects chromatin structure and may influence transcription factor binding. | ||||||
GSK 525762A | 1260907-17-2 | sc-490339 sc-490339A sc-490339B sc-490339C sc-490339D | 5 mg 10 mg 50 mg 100 mg 1 g | $300.00 $540.00 $940.00 $1680.00 $5900.00 | ||
Another BET bromodomain inhibitor; could affect TFIIIC63 function by altering chromatin accessibility. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Histone deacetylase inhibitor; affects chromatin structure and may influence TFIIIC63 binding. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Binds to GC-rich DNA sequences, potentially affecting transcription factor binding sites. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Inhibits the spliceosome, which could indirectly affect transcription. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
A pre-mRNA splicing inhibitor; could indirectly affect transcription. | ||||||